000 01228 a2200313 4500
005 20250516100251.0
264 0 _c20121221
008 201212s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-12-0577
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaniels, Molly S
245 0 0 _aLifetime cancer risks of PTEN mutation carriers--letter.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cAug 2012
300 _a4213; author reply 4214 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCodon, Nonsense
650 0 4 _aFemale
650 0 4 _aGerm-Line Mutation
650 0 4 _aHamartoma Syndrome, Multiple
_xgenetics
650 0 4 _aHumans
650 0 4 _aMutation, Missense
650 0 4 _aPTEN Phosphohydrolase
_xgenetics
700 1 _aRich, Thereasa
700 1 _aWeissman, Scott
700 1 _aPilarski, Robert
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 18
_gno. 15
_gp. 4213; author reply 4214
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-12-0577
_zAvailable from publisher's website
999 _c21886618
_d21886618